Lilly Wins TRO Battle In Byetta Marketing Case
A California federal judge on Wednesday lifted an order blocking Eli Lilly & Co. from selling Amylin Pharmaceuticals Inc.'s diabetes drug Byetta alongside a rival company's drug, saying Amylin's fears about...To view the full article, register now.
Already a subscriber? Click here to view full article